Introduction
T he placenta is a transitory organ that develops during pregnancy at the feto-maternal interface. It consists of 3 distinct layers: the amnion and chorion, both of fetal origin, and the maternal decidua. The chorionic villous placenta contains a rich vasculature to supply oxygen and nutrients to the fetus [1] [2] [3] [4] via chorionic villi that are the vascular projections structured by an outer layer of trophoblastic cells and inner part of fetal blood vessels. These numerous blood vessels result from neovascularization followed by active angiogenesis. Capillaries initially form de novo in the chorionic villi from hemangiogenic progenitors, which in turn engender endothelial networks through successive steps of differentiation and proliferation under the influence of trophoblast cells [5, 6] . Angiogenesis continues during placentation with development of both endothelial and perivascular cells [2, 7, 8] .
The placenta is rich in stem=progenitor cells. While the amnion has been reported to contain epiblast-derived pluripotent= multipotent stem cells (aka human amniotic epithelial cells) that express embryonic stem cell markers [4, [9] [10] [11] [12] [13] [14] , placentaderived mesenchymal stem cells (MSCs) have been isolated from all 3 layers (amnion [3, 15, 16] , chorion [17] [18] [19] , and decidua [3, 20] ). Human trophoblastic stem cells were isolated from the human villous placenta over 4 decades ago [7] , and yet the most recent studies on placental MSC still rely on mundane, indirect isolation strategies, on a par with the lack of knowledge on the identity of these cells [17] [18] [19] 21, 22] .
We previously identified microvascular pericytes as a major and ubiquitous source of human MSC in various fetal and adult organs [23] , including fetal placenta. While additional cell populations may act as mesenchymal progenitors in particular tissues such as fat [24] , pericytes represent an unique and consistently detectable population of cells in all organs, which express a specific set of surface antigens, including the cell adhesion molecule CD146 [25] and the proteoglycan NG2, and lack endothelial and hematopoietic cell markers. On the basis of this distinct cellular signature, we showed that pericytes can be reliably isolated as CD146þ CD34ÀCD56ÀCD45À cells from various organs, including placenta [23] . Muscle-derived pericytes belong to a collection of distinct myogenic stem=progenitor cells [26] [27] [28] , and efficiently regenerate skeletal muscle. Yet, pericytes exhibit robust myogenic potential independently of their tissue origin, as pericytes sorted from pancreas, adipose tissue, and placenta are also myogenic [23, 25] .
In the present work, we characterized in detail placenta villus cell subsets and their myogenicity. First, we documented the myogenic potential in vivo of intact, undissociated villus fragments. We then evaluated in detail the intrinsic properties of migration, adhesion, and MSC phenotype of expanded pericyte-like and nonpericyte populations. We finally compared the in vitro and in vivo myogenic potentials of freshly isolated placenta pericytes and nonpericyte populations, as well as their angiogenic capacities in vivo. Together, our findings suggest the abundant existence of highly migratory and myogenic perivascular mesenchymal progenitor cells within the placental vasculature. On the basis of these results, we propose placenta as a convenient, rich source of newly generated blood vessels suitable for cellular therapeutic applications.
Materials and Methods

Isolation of purified villous fragments from the human fetal placenta
After informed consent, in compliance with the Institutional Review Board (protocol number 0506176) at the University of Pittsburgh, placentas were obtained from midgestation (18-23 weeks) interrupted pregnancies. Bundles of chorionic anchoring (stem) villi were separated from the chorionic plate and spread out using forceps to separate individual villi from each other (Fig. 1A, b-d) . The villi were washed multiple times in phosphate buffered saline (PBS; Sigma, St Louis, MO) until blood cells and tissue debris were removed (Fig. 1A, e) . Terminal parts of the villi were cut off to avoid the presence of any decidual tissue (Fig. 1A, f) . Dissected villi were cut into *1-mm 3 pieces (Fig. 1A, g ) for in vitro culture=assay or transplantation into mouse muscles.
Immunofluorescence staining of placental blood vessels
For in toto immunofluorescence staining (Fig. 1B) , dissected villi were placed on glass slides and immunostained. Villus fragments were successively incubated with unconjugated mouse anti-human CD34 (BD Biosciences, 1:100) followed by goat anti-mouse-biotin (Dako, 1:500), and streptavidin-Cy3 (Sigma, 1:500). Next, anti-CD146-FITC (AbD Serotec, 1:50) was added for 2 h at room temperature (RT). 4 0 ,6-Diamidino-2-phenylindole (DAPI; Molecular Probes, 1:2000) was added to stain nuclei. Tissue was washed in PBS after each incubation. Photographs were captured using a Nikon Eclipse TE2000-U microscope and Snap Advanced software.
For cross-sectional staining (Fig. 1C) , dissected villi were embedded in tissue freezing medium (Triangle Biomedical Sciences), frozen in liquid nitrogen vapors, cryosectioned at 6-7 mm, and immunostained, as previously described [23, 29] . Frozen sections were fixed in a mixture of cooled (À208C) methanol and acetone (1:1) for 5 min before staining. Sections were blocked using 5% goat serum for 1 h at RT and incubated overnight at 48C with either unconjugated mouse antihuman CD34 (BD Biosciences), CD56 (BD Pharmingen), CD133 (Miltenyi Biotec), CD144 (Santa Cruz Biotechnology), CD146 (BD Biosciences), or KDR (vascular endothelial growth factor receptor-2; Santa Cruz Biotechnology, all 1:100). Then, goat anti-mouse-biotin (Dako) and streptavidinCy3 (Sigma) were incubated sequentially. Alternately, sections were stained in addition with anti-alpha-smooth muscle actin-FITC (aSMA; Sigma, 1:200), actin-CD31-FITC (Santa Cruz Biotechnology, 1:50), or actin-CD146-FITC (AbD Serotec) followed by DAPI staining. Photographs were captured using a Nikon Eclipse TE2000-U microscope or Olympus FLUOVIEW FV1000.
For immunocytostaining, cells grown out of placenta villi were plated in 48-well plates at 2Â10 4 cells=cm 2 and fixed using a mixture of cooled (À208C) methanol and acetone (1:1) for 5 min. Cells were then incubated overnight in unconjugated rabbit anti-human PDGF receptor-b (PDGFR-b; Santa Cruz Biotechnology), mouse anti-human NG2 (BD Biosciences), CD31 (Chemicon), CD144 (Bender MedSystems), or CD146 (BD Biosciences) (all 1:100). PDGFR-b staining was revealed using donkey anti-rabbit-Alexa 488 (Molecular Probes, 1:500) secondary antibody. For all other mouse anti-human unconjugated antibodies, cells were sequentially incubated with biotinylated goat anti-mouse (Dako) and streptavidin-Cy3 (Sigma). Additionally, some cells were costained with anti-aSMA-FITC (Dako), anti-CD34-FITC (Miltenyi Biotec, 1:50), anti-CD146-FITC (AbD Serotec), or anti-von Willebrand factor-FITC (vWF, US Biological, 1:100), followed by DAPI staining.
Villus fragment culture
Dissected villi were cultured intact on 24-well plates with or without 0.2% gelatin coating either in muscle proliferation medium (PM) containing Dulbecco's modified Eagle's medium (Invitrogen), 10% fetal calf serum (FCS, Invitrogen), 10% horse serum (Sigma), 1% chick embryo extract, and 1% penicillin=streptomycin (PS; Invitrogen), or in endothelial growth medium-2 (EGM2; Lonza). When outgrowing cells reached over 80% confluency, the villi pieces remaining intact were carefully removed, transferred into, and subsequently cultured on new gelatin-coated or noncoated plates. This procedure was repeated till the 5th outgrowth. Monolayers of outgrown cells were further expanded additional 3-5 passages in alpha-MEM (Invitrogen) supplemented with 20% FCS and 1% PS, and then used for cell sorting or analyses.
Myogenic differentiation in vivo
Four pieces of dissected villi (1 mm 3 each) were transplanted into a surgical pocket within the gastrocnemius muscle of a dystrophic SCID=mdx mouse. Animals were sacrificed 2 and 4 weeks after transplantation. Harvested muscles were frozen in cooled 2-methylbutane between À508C and À608C, and cryosectioned at 6-8 mm. Sections were fixed in a mixture of cooled (À208C) methanol and acetone (1:1) for 5 min before staining. Nonspecific antibody binding was blocked with 5% goat serum and permeablized 0.1% Triton in PBS. Sections were incubated overnight at 48C with mouse anti-human dystrophin (hDys3, Novocastra, 1:20), anti-spectrin (Novocastra, 1:100), anti-lamin A=C (Novocastra, 1:100), or anti-human nuclear antigen (Chemicon, 1:50) antibodies, followed by goat anti-mouse-biotin (Dako) and streptavidin-Cy3 (Sigma).
Freshly isolated CD146ÀCD34þCD45ÀCD56À, CD146þ CD34ÀCD45ÀCD56À, CD146ÀCD34ÀCD45ÀCD56À, and unsorted cells from fetal placenta villi were injected into the 452 PARK ET AL.
gastrocnemius muscles of dystrophic SCID=mdx mice. Each muscle received 2Â10 4 cells and was harvested 4 weeks posttransplantation. Muscles were processed as described above and stained with rabbit antidystrophin antibody (Abcam, 1:100) followed by secondary donkey anti-rabbit antibody coupled to Alexa 488 (Molecular Probes, 1:500).
Myogenic differentiation in vitro
Cells were plated at 2Â10 4 cells=cm 2 in muscle PM. At 60%-70% confluence, the culture medium was half diluted in Dulbecco's modified Eagle's medium (to reduce the serum concentration). Culture medium=serum concentration was successively reduced daily until a concentration of 2% was reached. The medium was then renewed every other day until multinucleated cells were observed. Differentiated cells were fixed in cooled methanol (À208C) for 5 min before staining. Cells were permeablized with 0.3% Triton in PBS. Mouse anti-human desmin (Sigma, 1:100) was incubated with cells overnight at 48C. Goat anti-mouse biotin (Dako) and streptavidin-Cy3 (Sigma) were then incubated sequentially.
Flow cytometry analysis and cell sorting
Outgrown villi cells were trypsinized, washed, and stained with mouse anti-human CD44-PE (Invitrogen), CD73-PE (BD Biosciences), CD90-PE (Immunotec), CD105-PE (Invitrogen), and CD146-FITC (AbD Serotec) (all 1:100). Each incubation was performed for 20 min at 48C.
Alternatively, 2 g of chorionic villi was minced and suspended in 20 mL of collagenases type I, II, and IV (all at 1 mg=mL; Sigma). After a 30-min incubation on a rotating device (150 rpm) at 378C, trypsin was added (final concentration 0.25%, Invitrogen) for another 10 min. Cells were filtered through a 70-mm cell strainer and washed free of enzymes. The cell pellet was re-suspended in red cell lysis buffer for 15 min at RT. After another centrifugation, cells were incubated for 30 min at 48C with mouse anti-human CD34-PE (DAKO), CD56-PE-Cy7 (BD Biosciences), CD45-APC (BD Biosciences), CD146-FITC (Serotec) (all 1:50), and 7-aminoactinomycin D (7-AAD; BD Biosciences; 1:100). Cells were analyzed and sorted using a FACSAria flow cytometer (Becton-Dickinson) with FACSDiva software (Becton-Dickinson).
Migration (wound healing) assay in vitro
Cells were plated in 12-well plates at a density of 5Â10 5 cells=well in a-MEM supplemented with 20% FCS, 1% PS, and cultured until confluent. A single straight wound was created in the center of the resulting monolayers using a sterile plastic pipette tip [30] . Cells were washed twice in PBS and cultured in a-MEM supplemented with 2% FCS, 1% PS to reduce proliferation. Each population was cultured in triplicate wells and photographed (3 pictures per well) at day 0 (postwound) and day 1 (24 h later). Average distance at day 0 (D 0 ) was calculated from the mean of 4 distances between cells on either side of the wound per picture. Average distance at day 1 (D 1 ) was calculated from the mean of at least 10 distinct distances between cells per picture. Migration rate (%) was calculated according to the following equation:
Adhesion assay
Cells were plated at 2Â10 5 cells=well in 6-well plates, which were either uncoated, or precoated overnight with type I collagen, 0.2% gelatin, 2 mg=cm 2 fibronectin, or 1 mL=well undiluted FCS. One hour later, floating cells were removed and adherent cells were fixed in 1% paraformaldehyde for 15 min at RT, and then stained with DAPI (Molecular Probes). Five images were randomly captured from each well to provide the average numbers of cells attached in each condition (n ¼ 3).
Real-time quantitative reverse transcriptasepolymerase chain reaction
Total RNA was extracted from 2Â10 4 or more cells using the Nucleospin RNA kit (Clontech). cDNA was synthesized with SuperScriptÔ II reverse transcriptase (Invitrogen), according to manufacturer's instructions. cDNA and primers were added to SYBR Green PCR master mix (Applied Biosystems) according to manufacturer's instructions. The quantitative analysis was performed by the Genetics Core Laboratory at the University of Pittsburgh. All data were normalized to human cyclophilin, which was used as an internal control. The primer sequences are listed in Supplementary Table S1 (Supplementary Data are available online at www.liebertonline.com=scd).
Statistics
Data are summarized as average AE standard deviation. Statistical comparison between groups was performed using 2-tailed Student's t-test (95% confidence interval). P values are listed in the figures.
Results
Isolation and characterization of placental villi
Over 20 individual placentas were used for this project. Developmental stages ranged between 17 and 23 weeks of gestation (20.4 AE 1.9 weeks, n ¼ 18) and weights averaged 27.1 AE 10.6 g (n ¼ 6). Bundles of chorionic villi attached to the chorionic plate were easily distinguishable (Fig. 1A, a, b) .
Fetal blood vessels located near the surface and inside of villi were detected by in toto immunostaining, revealing the whole vascular anatomy (Fig. 1B, c) constituted of luminal endothelial CD34þ cells (Fig. 1B, a) and perivascular CD146þcells (Fig. 1B, b) . Observation of immunostained villus cross sections confirmed fetal blood vessels to be composed of CD34þCD144þ endothelial cells surrounded by CD146þ perivascular cells (Fig. 1C, a (Fig. 1C, f) .
Intramuscular transplantation of placental villi
As a first attempt to assess the inherent myogenic potential of human placenta blood vessels, we transplanted intact dissected villus fragments (Fig. 1A, g ) into surgical pockets made in the gastrocnemius muscles of dystrophic SCID=mdx mice. The presence of human cells and myofibers was investigated at 2 and 4 weeks after transplantation. Observation of cross sections through host muscles revealed that human placental implants retained their native structure at 2 weeks post-transplantation ( Fig. 2A-F, dashed circles) . Human cells were identified inside the implants by detection of human-specific proteins, human nuclear antigen (hNA, Fig.  2E ), and human lamin A=C (Fig. 2F) . Human placenta participated in muscle regeneration, as assessed by the detection of human dystrophin-positive (hDys3þ) myofibers not only close to the engrafted area (Fig. 2B, dashed square) , but also in more distant regions, suggesting the migration of implanted human cells (Fig. 2B , lined square shown at higher magnification in 2-C).
Human myofibers detected by human dystrophin (Fig.  2G ) and spectrin expression (Fig. 2H) were typically clustered and mostly small in diameter with single centered nuclei, which are distinctive features of early muscle regeneration (Fig. 2G, I ). To demonstrate that these newly regenerated myofibers are truly of human origin, and not an intermediate product of cell fusion, we costained chimeric mouse muscle sections with antibodies to human-specific lamin A=C and spectrin. Human lamin A=C, shown in pink,
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is colocalized in central nuclei with DAPI staining (blue), and human spectrin (red) is exclusively expressed on the sarcolemma of myofibers (Fig. 2I ) [31] . SCID=mdx mice that underwent sham surgery without receiving human villus segments were used as negative controls, in which muscle sections did not show any positive signal after incubation with the anti-human antibodies (data not shown).
Cell outgrowth in cultures of total placental villi
After revealing the myogenic potential of total placental villi in vivo, we proceeded to explore the progenitor cell characteristics of various cell populations residing in placental villi, including CD146þ perivascular cells. Small pieces (1 mm 3 ) of intact placental villi (Fig. 1A, g ) were cultured on gelatin-coated or noncoated plates in EGM2 or muscle PM. Tissue adherence often failed on noncoated plates but was significantly enhanced in the presence of gelatin (or collagen type IV). Five to 7 days later, outgrowth of cells was first observed, and then sustained. Replating villus fragments for additional outgrowth followed by the first outgrowth step led to faster cell outgrowing and higher proliferation on gelatin-coated plates in EGM2 than all other conditions ( Supplementary Fig. S1 ). Cells outgrown from villus fragments in EGM2 were of polygonal morphology and proliferated rapidly (Fig. 3A , upper row; Supplementary Video S1), whereas cells outgrown in PM were spindle shaped, resembling fibroblasts (Fig. 3A, lower row) .
Proliferation was measured using the live cell imaging system, a fully automatic robotic videomicroscopy system that captures images of cell growth every 12 h for 6 days. EGM2 significantly enhanced cell proliferation rate, as compared to PM (Fig. 3B ). There were no major differences in growth rate between cells cultured in coated or noncoated plates. However, the addition of extracellular matrix induced the growth of different cell populations. When dissected villi 
circled area). (G-I)
Immunofluorescence staining of chimeric mouse dystrophic muscle. Human myofibers generated from the transplanted human placenta fragments express human dystrophin (hDys3, G, red) or human spectrin (hSpectrin, H, red). (I) Staining of hSpectrin (myofiber membrane) and lamin A=C (nuclei) confirms that spectrinþ myofibers were contributed by human cells. Nuclei were stained with Dapi (blue). Scale bars are 500 mm in A and B; 50 mm in C-I. Color images available online at www.liebertonline.com=scd.
were cultured in EGM2 on gelatin-coated plates, CD146 and NG2 double-positive cells-ie, pericytes [23] -were present, which was not observed in noncoated plates (Fig. 3C) . We therefore favored the outgrowth and propagation of pericytes from dissected placental villi using gelatin-coated plates and EGM2. Cells outgrown in these conditions were immunocytostained in 48-well culture plates. Most cells expressing CD146 were also positive for PDGFR-b and NG2, further indicating their perivascular origin [23, 26, 27, 32, 33] . Few CD146-positive cells expressed aSMA, and cells outgrown from villi rarely expressed the endothelial cell markers CD31, CD34, CD144, and vWF (Fig. 3D) .
MSC marker expression by cultured villus cells
On the basis of our immunocharacterization of cells outgrown from placenta villi, only 2 major cell populations could emerge under our culture conditions (EGM2 in gelatin-coated plates): (1) cells expressing pericyte markers and (2) cells lacking pericyte markers. Using fluorescence-activated cell sorting (FACS), we applied our previously published gating strategy [23] to isolate both populations. Cells outgrown from placenta villi were sorted as CD146þCD34ÀCD45ÀCD56À pericytes and CD146ÀCD34ÀCD45ÀCD56À nonpericyte cells. As observed by immunofluorescence staining, few or no endothelial cells could be detected (Fig. 3) . Similarly, hardly any CD45þ and CD56þ cells were present in our cultures. Consequently, no major cell population was excluded as per this purification strategy that allowed us to eliminate remaining endothelial and hematopoietic cells.
Thereafter, sorted CD146þCD34ÀCD45ÀCD56À (CD146þ) cells and CD146ÀCD34ÀCD45ÀCD56À (CD146À) cells were further cultured up to passage 5 and analyzed by flow cytometry. Both populations strongly and homogeneously expressed the MSC markers CD105 and CD44. CD73 expression was detected in 57.2% and 77.4% of expanded CD146þ and CD146À cells, respectively (Fig. 4B ). Yet, analysis of CD90 expression revealed a major difference between both popula- 
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tions. Over 60% of CD146þ cells were positive for CD90 expression, whereas <5% of CD146À cells were (Fig. 4A, B) . We examined brachyury mRNA, an early mesodermal stem cell marker, in these 2 cell populations. Higher levels of brachyury mRNA were detected in CD146þ cells (Fig. 4C , lane 2) than in CD146À cells (Fig. 4C, lane 3) . GAPDH mRNA expression was used as an internal control (Fig. 4C, lanes 4 and 5) .
Migration and adhesion of CD146þ and CD146À villus-derived cells
Cells outgrown from placenta villi as described above were sorted on expression of CD146 (and absence of CD34, CD45, and CD56) for further evaluation in terms of migration and adherence. CD146þ, CD146À, and unsorted cells were plated and grown to over 90% confluency. A single wound was created in the center of the cell monolayer (764 AE 152.6 mm, n ¼ 12) to observe empty space filling by migrating cells (Fig. 5A, day 0) . After 24 h, CD146þ cells demonstrated quantitatively higher migratory efficiency compared to both CD146À and total unsorted cells (Fig. 5A, day 1, and 5B).
Adhesion regulates multiple aspects of cell life via a variety of molecules and ligands [30, [34] [35] [36] [37] . To test the behavior of villus-derived cells in the presence of different adhesion molecules, sorted CD146þ and CD146À cells were seeded on different extracellular matrix substrates. Both populations were plated, in equal numbers, onto either noncoated, FCS saturated, collagen-, gelatin-, or fibronectin-coated culture plates. One hour later, unattached cells were removed and adherent cells were counted. CD146þ cells adhered faster than CD146À cells to all tested extracellular coating materials: collagen, gelatin, and fibronectin. Conversely, CD146À cells attached slightly faster on noncoated plates and those saturated with FCS (Fig. 5C) .
To further comprehend the distinct cell migration and adhesion properties of CD146þ cells, compared to their CD146Àcounterparts, we studied their expression of related genes. As assessed by real-time quantitative reverse transcriptase (RT)-polymerase chain reaction, CD146þ cells expressed integrin-alpha (Int-a) 1, 2, 4, 5, 6 , integrin-beta 1 (Intb1) and metalloproteinase-2 at higher levels than CD146À cells (Fig. 5D) . Interestingly, Int-a5 (a subcomponent of the fibronectin receptor) was expressed in excess of 9-fold higher, and Int-a6 (a subcomponent of the collagen receptor) was expressed 4-fold more by CD146þ cells than CD146À cells. Strikingly, metalloproteinase-2 is expressed >25-fold higher by CD146þ cells, consistent with our observations that CD146þ cells migrate more actively than CD146À cells (Fig. 5D) .
In vitro myogenesis from freshly sorted placental cells
After enzymatic digestion, placenta villus cells were purified by FACS into CD146þCD34ÀCD45ÀCD56À (CD146þ cells), CD146ÀCD34þCD45ÀCD56À (CD34þ cells), and CD146ÀCD34ÀCD45ÀCD56À (CD34ÀCD146À cells) cell populations. Villus cell suspensions included 31 AE 11.7% CD45þ hematopoietic cells (n ¼ 3). After gating out CD45þ and CD56þ cells, CD34þ endothelial=adventitial cells (3.5 AE 2.6%, n ¼ 8) and CD146þ perivascular cells (1.68 AE 0.78%, n ¼ 8) could be clearly delineated (Fig. 6A) . CD146þ CD34þCD45ÀCD56À endothelial cells accounted for <1% or were absent. In postsort culture, perivascular cells developed elongated cytoplasmic arms, whereas endothelial cells typically exhibited a polygonal morphology, consistent with our previous observations [23] (Fig. 6B) .
Culture-expanded cells were plated at a density of 2Â10 4 cells=cm 2 and cultured under conditions promoting myogenic differentiation. Fifteen days later, both CD34þ and CD146þ populations included significantly higher numbers of desminþ cells (Fig. 6C, D) than unsorted or CD34À CD146À cells. However, the morphology of newly generated desminþ cells differed between these populations. CD146þ cells formed elongated, occasionally multinucleated myofibers, whereas CD34þ cells generated exclusively mononucleated, scattered desminþ cells (Fig. 6C) .
To confirm the differentiation into the myogenic cell lineage, we further examined mRNA expression of CD56 
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(N-CAM), a commonly used marker of myoblasts [28, [38] [39] [40] , in vascular cells (CD34þ and CD146þ), nonvascular cells (CD34ÀCD146À), culture-expanded unsorted cells (total), and freshly isolated unsorted cells (case 1 and case 2, representing 2 distinct donors). Human fetal muscle was used as a positive control. CD56 was upregulated after myogenic differentiation in all populations. However, CD146þ cells showed the highest CD56 expression level postdifferentiation, which was even substantially higher than in human fetal muscle (Fig. 6E, far right) .
In vivo myogenesis and promotion of local angiogenesis by freshly sorted placenta cells
We next examined the myogenic and angiogenic capacities of the different freshly purified placental cell populations by injections into gastrocnemius muscles of immunodeficient dystrophic (SCID=mdx) mice. We injected per muscle 1Â10 freshly sorted CD146ÀCD34þCD45ÀCD56À endothelial, CD146þCD34ÀCD45ÀCD56À perivascular, CD146ÀCD34À CD45ÀCD56À nonvascular, or unsorted (total) cells. Two weeks postinjection, host muscles were harvested, cryosectioned, and stained with antibodies against both human and mouse dystrophin and vWF.
Both CD146þ and CD34þ sorted vascular cells generated clusters of dystrophinþ myofibers after injection into SCID=mdx mice. Injection of nonvascular cells only resulted in the formation of low numbers of separated single myofibers. Unsorted cells were injected as a control and gave rise to an intermediate number of myofibers, compared to vascular and nonvascular cell populations (Fig. 7A) .
Tissue regeneration after injury is positively correlated with angiogenesis=neovascularization [41] . Blood vessels supply the damaged area with nutrients and oxygen, and support the migration of progenitor cells from the bone marrow or other sites [28, 30, [41] [42] [43] [44] [45] . All human cell-injected SCID=mdx mouse muscles contained more blood vessels than PBS-injected muscles (Fig. 7B) . Interestingly, CD146þ cell injection resulted in significantly higher numbers of blood vessels than that of the other populations. Mid-gestation human fetal muscle (fMuscle) was processed in the same manner for comparison (Fig. 7C) .
We have no evidence that perivascular cells could differentiate into endothelial cells in our transplantation setting. However, perivascular cells produce angiogenic factors such as basic fibroblast growth factor, heparin binding-epidermal growth factor-like growth factor (HB-EGE), keratinocyte growth factor, and vascular endothelial growth factor [25] and have the ability to organize blood vessel development from the host endothelial cells [46, 47] . On the basis of published results and our own knowledge, perivascular cells promote angiogenesis via secretion of angiogenic factors or by recruiting domestic endothelial cells but are less likely to trans-differentiate into endothelial cells.
Discussion
Satellite cells can naturally regenerate skeletal myofibers lost to exercise, disease, or injury. Besides this wellcharacterized, committed muscle-residing progenitor, several multipotent mesodermal stem cells localized within skeletal muscle (myo-endothelial cells) or of broader tissue distribution (mesoangioblasts, MSCs, and pericytes) are also experimentally myogenic, although a genuine role for these cells in muscle homeostasis has not yet been demonstrated [25] . We have indeed previously observed that pericytes sorted to homogeneity by flow cytometry from multiple human organs, including the placenta, are immediately myogenic in culture or after xenogeneic transplantation into injured or diseased muscles [23] .
We have now explored in much more detail the myogenic potential of human placental pericytes: first, because the naturally shed placenta is of unlimited availability as a source of therapeutic cells; second, because the abundant vasculature of placental villi can be mechanically dissected as an intact network of diversely sized blood vessels, as illustrated by Fig. 1 . Successful transplantation of human placental villi under the kidney capsule of immunodeficient mice has been previously reported [48] . Here we transplanted dissected human chorionic villi intramuscularly into immunodeficient dystrophic mice, and numerous human 
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myofibers were generated around the implants. This result is important as it shows that perivascular cells do not exhibit myogenic potential-and possibly other developmental abilities-exclusively when dissociated from adjacent endothelial cells and purified by flow cytometry [23, 26] . This should be at difference with the adipogenic potential of fat tissue perivascular cells, which is inhibited by association with endothelial cells [49] . Alternatively, as an intermediate possibility, placental perivascular cells responded to the compromised muscle environment by migrating away from the endothelium, which stimulated a previously repressed myogenic potential. Besides pericytes, did other placental cells participate in the observed myogenesis? Immunostaining of isolated placenta vessels in toto revealed the expected presence of endothelial cells and pericytes, which express CD34 and CD146, respectively. In our optimized version of the villous explant culture [50, 51] , 2 major cell populations grew from placental villi: pericyte-like CD146þCD34ÀCD45ÀCD56À cells and CD146ÀCD34ÀCD45ÀCD56À nonpericytes. CD34þ, CD31þ, and CD144þ endothelial cells were rapidly overgrown by these 2 cell populations. Both CD146þ and CD146À cell subsets outgrown from placental villi were sorted by FACS and further cultured separately. The pericyte origin of CD146þ cells was confirmed by their coexpression of other pericyte as well as MSC markers [23] , and their multilineage mesodermal developmental potential (Supplementary Fig. S2 ). On the basis of these observations, and their high level of brachyury mRNA expression, CD146þ pericyte-like cells grown from placental villi appeared to be closely related to bone marrow-MSC [52] , and likely represent the myogenic cell contingent evidenced in the above described transplantation experiments. To further document the affiliation of these cultured cells, both CD146þCD34À CD45ÀCD56À and CD146ÀCD34ÀCD45ÀCD56À cells-as well as CD146ÀCD34þCD45ÀCD56À cells-were detected and sorted by FACS from the native placenta and injected intramuscularly into immunodeficient dystrophic mice. Perivascular (CD146þCD34ÀCD45ÀCD56À) and, to a far lesser extent, CD146ÀCD34þCD45ÀCD56À cells gave rise to differentiated dystrophin-expressing myofibers in the immunodeficient hosts, but only limited numbers of human myofibers were produced by CD146ÀCD34ÀCD45ÀCD56À cells, confirming the observations made on cultured villus blood vessels. Not only were placenta pericytes myogenic, they also significantly improved local angiogenesis, in agreement with the observation that multipotent placental MSCs (hPMSCs) can be isolated from term human placenta that are angiogenic [53] . This further suggests that MSCs and their ancestors can also mediate tissue repair by secreting growth factors [22] .
The results reported here confirm and extend our conclusions regarding the existence in human organs of pericytes endowed with multilineage mesodermal potential, at the origin of MSCs once culture-adapted [23, 25, 33, 54] . Clearly, the CD146þCD34ÀCD45ÀCD56À pericytes described around placental microvessels have a definitive advantage over neighboring cell populations in terms of growth and migration in vitro, and are the most potent as regard myogenicity. Pericytes are not, however, the only myogenic cells present in human placenta, as we have also detected power to generate myofibers within CD146À CD34þCD45ÀCD56À cells. Most likely, these latter cells belong to the pool of perivascular MSC ancestors of the same phenotype we have recently identified in the tunica adventitia of human arteries and veins as the stem cell equivalents in larger vessels of microvascular pericytes (Corselli et al., submitted for publication). We show in essence that the richly vascularized placenta is a convenient and abundant source of blood vessel associated stem cells.
